Pay in 4 interest-free payments of $5.49 Learn more
Ships within 48 hours · Estimated delivery Sep 28 - Oct 3
A phase I study assessing the safety, tolerability, immunogenicity, and low-density lipoprotein cholesterol-lowering activity of immunotherapeutics targeting PCSK9
Mutt SJ, Hyppnen E, Saarnio J, Jrvelin MR, Herzig KH
The tablet form makes it convenient to take anytime without mixing powders or drinks
Eissele R, Goke R, Willemer S, Harthus HP, Vermeer H, Arnold R, and Goke B
US$ 26.71
US$ 22.42
US$ 22.06
US$ 22.65
US$ 29.06
US$ 20.65
US$ 26.95
US$ 27.76
US$ 28.27
US$ 21.62
US$ 20.78
US$ 27.23
